COVID-19 References

Here is my outcome data since 3/18/20 - 3/26/20: 669 patients seen in my Monroe, NY practice with either test proven or clinically diagnosed corona infection; 0 deaths; 0 intubations; 4 hospitalizations for pneumonia - patients are on iv antibiotics and improving.

Title:  03/22/20 | Dr. Nathan Ritter
Description:  Treatments for COVID
Notes:  
Abstract:  

Let's take a look at the evidence behind the anti-malarial medications chloroquine and hydroxychloroquine as treatments for Coronavirus. I also briefly discuss quinine, which is closely related to the other two medications, and is being considered by some as another option for COVID-19, and give an update on where I stand on the ACE Inhibitor / ARB situation.

Title:  03/28/20 | Dr. Ivette Lozano
Description:  Treatment of COVID patients with hydroxychloroquine
Notes:  
Abstract:  

Dr. Ivette C. Lozano, MD explains safe hygiene versus false practices on Covid 19.

Title:  03/30/20 | Dr. Nathan Ritter
Description:  Hydroxychloroquine and Coronavirus Update: New Study from France
Notes:  
Abstract:  

I go through the recently published study by Gautret and others from Marseille and give my opinion about the results.

Title:  04/05/20 | Dr. Nathan Ritter
Description:  Hydroxychloroquine and Coronavirus Update... and What is Long QT?
Notes:  
Abstract:  

Two new Hydroxychloroquine studies were released this week, I go through the results. Also, I talk about Long QT and how it relates to Coronavirus infection.

Title:  04/07/20 | Dr. Anthony Cardillo
Description:  LA doctor seeing success with hydroxychloroquine to treat COVID-19
Notes:  
Abstract:  

A Los Angeles doctor said he is seeing significant success in prescribing the malaria drug hydroxychloroquine in combination with zinc to treat patients with severe symptoms of COVID-19.

Title:  04/10/20 | Dr Valdimir Zelenko
Description:  GVA conference with Dr. Vladimir Zelenko
Notes:  
Abstract:  

Dr. Vladimir Zelenko discusses the coronavirus COVID-19 symptoms and treatment with Head of GVA Russia Dr. Arthur Zulficarov and his colleagues.

Title:  04/11/20 | Dr. Nathan Ritter
Description:  Biggest Hydroxychloroquine / Azithromycin Study Yet! Vive la France! - Part 1
Notes:  
Abstract:  

The Marseilles group released their Covid-19 data on April 9th. The study is chock full of observations, the most important of which was a low mortality rate. This is part 1 of a two part series on the study.

Title:  04/13/20 | Dr. Nathan Ritter
Description:  Biggest Hydroxychloroquine / Azithromycin Study Yet! Vive la France! - Part 2
Notes:  
Abstract:  

The Marseilles group released their Covid-19 data on April 9th. The study is chock full of observations, the most important of which was a low mortality rate. This is part 2 of a two part series on the study.

Title:  04/15/20 | Dr. Oz
Description:  EXCLUSIVE: Dr. Oz Discusses The Hydroxychloroquine Study Outcome With Dr.Didier Raoult
Notes:  
Abstract:  

EXCLUSIVE: Dr. Oz Discusses The Hydroxychloroquine Study Outcome With Dr. Didier Raoult of France

Title:  04/19/20 | Dr Valdimir Zelenko
Description:  Dr. Vladimir Zev Zelenko: What works to defeat the virus? How to prevent or weaken the illness?
Notes:  
Abstract:  

Dr. Zelenko shares the story of his life and how his own lung cancer prepared him to fight for the lives of others.

Title:  04/22/20 | Laura Ingraham
Description:  The truth about hydroxychloroquine
Notes:  
Abstract:  

A new study released on hydroxychloroquine for use on COVID-19 patients is shockingly irresponsible and, as top virologists are saying, perhaps even agenda-driven.

Title:  04/23/20 | Dr Valdimir Zelenko
Description:  Dr. Vladimir Zelenko Explains Effective Coronavirus Treatment
Notes:  
Abstract:  

Dr. Vladimir Zelenko came on the Adam Carolla podcast today to talk about his effective treatment of the Coronavirus. It's surprisingly simple, surprisingly effective and most doctors have what they need for a possible cure on hand. According to Dr. Zelenko the whole process runs about $12. In this conversation he sites how this treatment has reduced death in those that follow his simple plan by 95%. Big Pharma doesn't want this message to be heard.

Title:  04/24/20 | Dr Valdimir Zelenko
Description:  A Conversation with Dr. Vladimir Zelenko
Notes:  
Abstract:  

Courtesy of The Frank Sontag Show and KKLA, we are please to share a conversation between Frank and Dr. Vladimir Zelenko. Early in the battle against COVID-19, his clinics have treated people with coronavirus and coronavirus-like symptoms using experimental treatments. His counsel has been sought after by President Trump and other leaders around the world. Don't miss this riveting conversation.

Title:  05/16/20 | Dr. Ivette Lozano
Description:  Dr. Ivette Lozano Dallas Tx speaking on Covid 19
Notes:  
Abstract:  

Title:  05/21/20 | Dr Valdimir Zelenko
Description:  Arutz Sheva speaks with Dr Vladimir Zev Zelenko
Notes:  
Abstract:  

Title:  05/24/2020 | Association of American Physicians and Surgeons
Description:  Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patients
Notes:  
Abstract:  

In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®). To date, the total number of reported patients treated with HCQ, with or without zinc […]

Title:  05/25/20 | Dr. Nathan Ritter
Description:  Hydroxychloroquine Civil War: Trump vs Cavuto, Who is right?
Notes:  
Abstract:  

President Trump and Neil Cavuto got into it this past week about Hydroxychloroquine. Will it save you or kill you?

Title:  06/02/2020 | The Gateway Pundit
Description:  President of El Salvador Announces That He is Taking Hydroxychloroquine, Says 'Most World Leaders' Doing the Same
Notes:  
Abstract:  

President of El Salvador Nayib Bukele has announced that he is taking hydroxychloroquine as a preventative measure against the coronavirus. Bukele told reporters on Tuesday that “most world leaders” are doing the same and has questioned why world leaders are being advised to use it while the public is not. “I use it as a…

Title:  06/07/2020 | The New American
Description:  Hydroxychloroquine Misinformation Can Be Deadly: Let Patients Decide
Notes:  
Abstract:  

Of the fake news and misinformation that has proliferated in this pandemic, the most harmful is the claim that hydroxychloroquine (HCQ) is a serious heart hazard. by Elizabeth Lee Vliet, M.D.

Title:  06/09/20 | Dr Valdimir Zelenko
Description:  Dr. Zelenko on Lancet, NEJM Retract Studies on COVID-19
Notes:  
Abstract:  

Two controversial studies of COVID-19 patients have been retracted after the authors failed to demonstrate that the data were reliable.

Title:  07/01/20 | Dr Valdimir Zelenko
Description:  Dr. Z has 99.3% Survival Rate for COVID-19 Patients; Urges America To Continue Reopening
Notes:  
Abstract:  

Rudy Giuliani sits down with Dr. Vladimir Zelenko, MD, Board Certified in Family Medicine, to discuss the protocol he used to achieve a 99.3% survival rate for his COVID19 patients. Dr. Zelenko urges America can continue to reopen and have maximum participation with the fallback of a very effective treatment regimen.

Title:  07/03/20 | Dr. Valdimir Zelenko
Description:  DR ZELENKO: HCQ DENIERS ARE “GUILTY OF MASS MURDER
Notes:  
Abstract:  

Title:  07/06/20 | Dr. Brian Procter
Description:  Texas physician talks about treating Covid 19 patients
Notes:  
Abstract:  

My doctor wrote a letter about a week ago that went viral regarding COVID-19, how he’s treating his patients and how in his opinion there is a bigger issue going on that is not being talked about. He recorded a video as a follow up.

Title:  07/07/2020 | Big League Politics
Description:  TRUMP WAS RIGHT: Medical Study Proves That Hydroxychloroquine Lowers COVID-19 Death Rate
Notes:  
Abstract:  

Title:  07/07/2020 | The Detroit News
Description:  Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds
Notes:  
Abstract:  

Heads of the Michigan health system said Thursday the study found the drugu00a0“significantly” decreased the death rate of patients

Title:  07/08/20 | Dr Valdimir Zelenko
Description:  Interview with Dr Zev Zelenko – Part 1
Notes:  
Abstract:  

We talk here about his treatment protocol, now known as The Zelenko Protocol, announced to the world on March 23, about the evolutions in the therapeutic approach, including regarding medications, and about personal protection for health care workers as well as about prophylaxis.

Title:  07/08/20 | Dr Valdimir Zelenko
Description:  Interview with Dr Zev Zelenko – Part 2
Notes:  
Abstract:  

In this second part of our interview with the esteemed Dr Vladimir Zelenko, we discuss how COVID-19 badly affected the Hasidic community both in New York and Montreal. He recounts in particular the tragedy of a young pregnant woman, in her 20s, in Montreal, who was not able to secure the required drugs for early treatment, who is still in intensive care, and who lost her baby. Dr Zelenko issues a call to the Canadian and other governments to adopt early treatment for COVID-19.

Title:  07/13/20 | Dr Valdimir Zelenko
Description:  BRAZ President Taking Hydroxychloroquine, Dr. Zelenko Weighs In
Notes:  
Abstract:  

Dennis Prager speaks to Dr. Vladimir Zelenko who argues that the Zelenko Protocol is safe and effective in treating the Coronavirus.

Title:  07/14/20 | Dr Valdimir Zelenko
Description:  Live Discussion with Dr. Zelenko on COVID-19 and the Zelenko Protocol
Notes:  
Abstract:  

Live Discussion with Dr. Zelenko and COVID-19; Zelenko Protocol; Hydroxychloroquine and Zinc.

Title:  07/22/2020 | Reuters
Description:  U.S. sends Brazil 2 million doses of hydroxychloroquine, drug touted by Trump
Notes:  The whole nation of Brazil has access to HCQ as a treatement for CV19
Abstract:  

The United States has supplied Brazil with 2 million doses of hydroxychloroquine for use against the coronavirus, the two governments said on Sunday, despite medical warnings about risks associated with the anti-malaria drug.

Title:  07/28/2020 | PubMed Central
Description:  Persistent hiccups as an atypical presenting complaint of COVID-19
Notes:  HCQ as a treatment for a particular CV19 symptom.
Abstract:  

Hiccups (singultus) are reflex inspiratory movements that involve the swallowing reflex arc and can be classified as acute (<48 h) or persistent (>48 h). A 62-year-old man with no history of malignancy or pulmonary disease presented to the Emergency Department with a four-day history of persistent hiccups. Other than episodic hiccupping, his physical examination was otherwise unremarkable. An abnormal chest X-ray led to a CT scan of the chest with IV contrast, which demonstrated regional, peripheral groundglass opacities of the upper lobes with small focal groundglass opacities scattered throughout the lungs. He was tested for COVID-19 per admission protocol, started on hydroxychloroquine, his hiccups improved, and he was discharged to home after 3 days. An emergency medicine physician should keep COVID-19 on the differential and be vigilant of exposure in atypical presentations.

Title:  07/31-2020 | CBN News
Description:  Hydroxychloroquine Study Finds the Drug 'Significantly' Cuts Death Rate
Notes:  
Abstract:  

A substantial new study has found that the anti-malaria drug hydroxychloroquine helped patients survive COVID-19. In fact, the study from the Henry Ford Health System in Michigan said the drug "significantly" cut the death rate of patients.

Title:  08/22/2005 | Virology Journal
Description:  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Notes:  
Abstract:  

Background Severe Acute Respiratory Syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available. Results We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage...

Title:  07/01/20 | Gilead Pharmaceuticals
Description:  Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19
Notes:  
Abstract:  

Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

Title:  07/17/2020 | Stanford University
Description:  How remdesivir works, and why it's not the ultimate coronavirus killer
Notes:  
Abstract:  

How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?

Title:  07/30/2020 | UGA Today – Leigh Beeson
Description:  Pharmacist clears up confusion about Remdesivir
Notes:  
Abstract:  

Remdesivir might shorten duration of symptoms in severely ill patients.

Title:  7/30/2020 | Chemical & Engineering News
Description:  What can initial remdesivir data tell us about tackling COVID-19?
Notes:  
Abstract:  

Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts.